OBI received notice from patent attorney’s office that product patent for OBI-822 named "Compound and Compositions of Carbohydrate Vaccine and Uses Thereof" has been approved by Taiwan Intellectual Property Office

Date of occurrence of the event: Oct 01, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A Cause of occurrence: OBI received notice from patent attorney’s office that product patent for OBI-822 named ” Compound and Compositions of Carbohydrate Vaccine and Uses […]